Pfizer (PFE)

EBITDA Growth

-40.76%

TTM · Period ending:

PFE logo

PFE EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-40.76%
PFE TTM EBITDA YoY % (7.45% → -40.76%)
High-resolution chart · PNG

PFE ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Pfizer EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-40.764%
-13.4915%
-19.1142%
53.0066%
315.1476%
167.1825%
117.0397%
-24.7798%
-81.7048%
-80.7206%
-76.7017%
-53.2993%
-21.9135%
13.183%
33.5058%
44.4758%
93.2126%
114.2614%
135.373%
139.0565%
-9.5398%
-32.1727%
-48.3199%
-56.2075%
12.944%
18.3039%
29.012%
21.8235%
-6.228%
-1.1033%
-1.3002%
9.0056%
19.0121%
26.6262%
29.7352%
39.3052%
15.9516%
-0.8959%
-0.1697%
-19.1116%
-18.3522%
-16.7084%
-19.9404%
-15.724%
-11.5998%
-14.435%
-19.0585%
-10.5325%
-7.39%
4.7568%
15.0175%
8.9909%
-0.1022%
-4.6302%
-10.8277%
-5.6704%
10.6779%
8.1167%
10.9496%
25.2091%
6.114%
20.3634%
23.1595%
-12.5451%
-5.1556%
-14.0627%
-15.5148%
11.315%
29.5328%
35.3911%
28.5273%
17.2524%
-16.5793%
-25.7025%
-20.6335%
-24.419%
-8.7832%
-1.8567%
-2.9788%
-1.549%
-6.2757%
-2.5905%
-3.2744%
8.8313%
25.7862%
25.7238%
40.9963%
40.5885%
29.5375%
24.2785%
14.6733%
11.1496%
10.1748%
8.2434%
7.1156%
7.537%
11.5413%
21.1302%
26.6723%
37.1391%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.